This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Centene Corporation Partners With MHM Services To Serve Massachusetts State Correctional System

ST. LOUIS, March 18, 2013 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that a subsidiary of its correctional healthcare joint venture, Centurion LLC ("Centurion"), has been notified by the Department of Correction in Massachusetts that it has been awarded a contract, contingent upon successful completion of contract negotiations.

Centurion is a joint venture between Centene and MHM Services Inc. ("MHM"), a national leader in providing healthcare services to correctional systems. The Centurion partnership leverages Centene's more than 25 years of experience with state-sponsored managed care programs and MHM's unique expertise in providing healthcare services to inmates over the past three decades. 

"Centene continues to expand its experience in working with state governments to provide better health outcomes at lower costs," said Jason M. Harrold, Executive Vice President, Specialty Companies, for Centene.  "Centurion offers states a unique model for the coordination and delivery of health services to inmates, while working to manage escalating costs for our state partners."

The Massachusetts Partnership for Correctional Health is the Centurion subsidiary that responded to the request for proposal from the Massachusetts Department of Correction. Under this award, Centurion will provide comprehensive healthcare services to individuals incarcerated in Massachusetts state correctional facilities.

"Under the Centurion partnership, MHM Services is pleased to expand its relationship with the Massachusetts Department of Correction to provide comprehensive medical services," said Michael S. Pinkert, Chairman and Chief Executive Officer for MHM Services.  "By joining with Centene, we are able to offer a new and unique approach to inmate healthcare that combines Medicaid managed care techniques with the more traditional approaches to treating inmates."

The award is subject to final negotiations with the state and is contemplated to become effective in the summer of 2013.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,846.53 +34.34 0.19%
S&P 500 2,091.70 +2.56 0.12%
NASDAQ 5,120.31 +17.5020 0.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs